CBT
REGN icon

Capital Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Capital Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-24
Closed -$12K – 560
2020
Q1 		$12K Buy
24
+3
+14% +$1.24K ﹤0.01% 534
2019
Q4 		$8K Sell
21
-4
-16% -$1.35K ﹤0.01% 579
2019
Q3 		$7K Buy
25
+4
+19% +$1.18K ﹤0.01% 580
2019
Q2 		$7K Buy
+21
New +$6.99K ﹤0.01% 568
2018
Q1 		– Sell
-15
Closed -$6K – 690
2017
Q4 		$6K Buy
+15
New +$6.08K ﹤0.01% 593

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital Bank & Trust's REGN Position: Q2 2020 in Review

Capital Bank & Trust sold out of Regeneron Pharmaceuticals (REGN) in Q2 2020, closing a stake of 24 shares — an estimated $12K sold.

Capital Bank & Trust first reported a position in REGN in Q4 2017 and held it in 5 quarters. The position peaked at $12K in Q1 2020. 932 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • Capital Bank & Trust reported no remaining Regeneron Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 24 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $12K.
  • Capital Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Capital Bank & Trust's Regeneron Pharmaceuticals position peaked at $12K in Q1 2020.
  • 932 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.